Covaxin doses production would reach 10 crores by September: Centre
The Central government on Wednesday informed that the current production capacity of Covaxin vaccine will reach 10 crore doses per month by September 2021.
Providing comprehensive details, the government mentioned the Covaxin vials will be doubled by May-June 2021 and then will be increased nearly 6-7 fold by July - August 2021 i.e increasing the production from 1 crore vaccine doses in April, 2021 to 6-7 crore vaccine dose/month in July - August. It is expected to reach nearly 10 crore doses per month by September 2021.
Issuing a press release on Wednesday, the Ministry of Science & Technology informed that a few weeks back, inter-ministerial teams had visited the sites of 2 main vaccine manufacturers to get their inputs on how production can be ramped up. In this period, there have been extensive reviews and feasibility studies on the plans being discussed with vaccine manufacturers.
Earlier the government has announced financial support to different firms including Bharat Biotech’s new Bangalore facility to ramp up the capacity of indigenously developed Covaxin.
Bharat Biotech’s Bangalore unit will receive financial support of Rs 65 crore as grant for enhanced production capacities.
Apart from Bharat Biotech, Maharashtra state-owned Haffkine Biopharmaceutical Corporation Ltd will also get around ₹65 crore for setting up a facility to have a production capacity of 20 million doses per month after getting functional.
Additionally, Indian Immunologicals Limited (IIL), Hyderabad- a facility under National Dairy Development Board and Bharat Immunologicals and Biologicals Limited (BIBCOL), will also be supported by government of India to prepare their facility to provide 10-15 million doses per month by Aug - Sep 2021.
Number of Reads: 56